Trial Profile
A Study to Evaluate the Effect of Roflumilast on The Levels of Collagen Type IV in Bronchoalveolar Fluid in Patients With Severe Chronic Obstructive Pulmonary Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jan 2016
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 13 Jan 2016 New trial record